Clindamycin Palmitate Hydrochloride

Babesiosis, Mitral Valve Prolapse, Toxoplasmosis + 39 more

Treatment

20 Active Studies for Clindamycin Palmitate Hydrochloride

What is Clindamycin Palmitate Hydrochloride

Clindamycin

The Generic name of this drug

Treatment Summary

Clindamycin is a type of antibiotic used to treat serious infections caused by bacteria. It can be taken orally or used topically on the skin to treat acne. It is more effective than its predecessor, lincomycin, and works against certain anaerobic bacteria, gram-positive cocci, bacilli, and gram-negative bacilli. Clindamycin also has some off-label uses in the treatment of toxoplasmosis, malaria, and babesiosis. It was first isolated in Lincoln, Nebraska from a soil sample and derived from lincomycin.

Cleocin Hydrochloride

is the brand name

image of different drug pills on a surface

Clindamycin Palmitate Hydrochloride Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Cleocin Hydrochloride

Clindamycin

1970

507

Effectiveness

How Clindamycin Palmitate Hydrochloride Affects Patients

Clindamycin works by stopping bacteria from making proteins, which helps stop them from multiplying. It must be taken every 6 hours to be effective. Taking clindamycin can lead to severe diarrhea and colitis, so it should only be used for serious infections where other antibiotics won't work. This drug is effective against many types of bacteria, but may not work against bacteria that have become resistant to it. Depending on the area, some bacteria may be resistant to this drug, so it's important to check with local health professionals to make sure it will work.

How Clindamycin Palmitate Hydrochloride works in the body

Clindamycin works by preventing bacteria from forming proteins. It does this by blocking the ribosome, a molecule responsible for making proteins. Clindamycin does this by imitating the shape of molecules that help make proteins. This stops bacteria from producing proteins that help it to survive. For acne, clindamycin works by attacking the bacteria that is associated with acne.

When to interrupt dosage

The prescribed measure of Clindamycin Palmitate Hydrochloride is contingent upon the diagnosed state, including viridans group streptococci, Vaginal Infections and Surgical Intervention. The measure of dosage is contingent upon the procedure of administration (e.g. Cream - Vaginal or Suspension - Topical) laid out in the table beneath.

Condition

Dosage

Administration

viridans group streptococci

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Heart Valve Prosthesis

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Communicable Diseases

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Respiratory Tract Infections

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Bone and Bones

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Acne Vulgaris

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Endometritis caused by Anaerobic Bacterial Infection

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

prophylaxis of Bacterial endocarditis

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Malaria

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

penicillins

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Bacteria, Anaerobic

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Hypertrophic Cardiomyopathy

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Surgical Intervention

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Pneumonia, Pneumocystis

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Mixed Vaginal Infections

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Respiratory Tract Infections (RTI) caused by susceptible streptococci

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Skin Structures and Soft Tissue Infections caused by susceptible streptococci

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Bone and Bones

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Heart Defects, Congenital

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Acne Vulgaris

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Granule, for solution, Granule, for solution - Oral, Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution - Intravenous, Injection, solution, Swab, Swab - Topical, Kit, Kit - Topical, Aerosol, foam - Topical, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Lotion, Lotion - Topical, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Liquid, Cream - Topical, Injection, Injection - Intravenous, Aerosol, foam, Injection, solution, concentrate - Intramuscular; Intravenous, Solution - Oral, Powder, for solution - Oral, Powder, for solution, Solution - Intravenous, Injection - Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Gel - Vaginal

Warnings

Clindamycin Palmitate Hydrochloride Contraindications

Condition

Risk Level

Notes

Enterocolitis, Pseudomembranous

Do Not Combine

Crohn Disease

Do Not Combine

Ulcerative Colitis

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Clindamycin may interact with Pulse Frequency

There are 20 known major drug interactions with Clindamycin Palmitate Hydrochloride.

Common Clindamycin Palmitate Hydrochloride Drug Interactions

Drug Name

Risk Level

Description

Astemizole

Major

The metabolism of Astemizole can be decreased when combined with Clindamycin.

Axitinib

Major

The metabolism of Axitinib can be decreased when combined with Clindamycin.

Bromocriptine

Major

The serum concentration of Bromocriptine can be increased when it is combined with Clindamycin.

Cabazitaxel

Major

The metabolism of Cabazitaxel can be decreased when combined with Clindamycin.

Cabergoline

Major

The serum concentration of Cabergoline can be increased when it is combined with Clindamycin.

Clindamycin Palmitate Hydrochloride Toxicity & Overdose Risk

The toxic dose of clindamycin in mice and rats is 2540mg/kg and 2190mg/kg, respectively. Although no cases of overdose have been reported, the symptoms may be similar to the side effects associated with clindamycin, such as stomach pain, nausea, vomiting, and diarrhea. In one case, a 3-year-old child who was given a 100mg/kg daily dose for 5 days had only mild abdominal pain and diarrhea. Activated charcoal may be used to remove any unabsorbed drug, but dialysis will not be effective. General supportive measures are recommended in cases of clind

Clindamycin Palmitate Hydrochloride Novel Uses: Which Conditions Have a Clinical Trial Featuring Clindamycin Palmitate Hydrochloride?

73 active trials are being conducted to evaluate the potential of Clindamycin Palmitate Hydrochloride to alleviate Bacterial Endocarditis, Acne and Pneumocystis Jirovecii Pneumonia.

Condition

Clinical Trials

Trial Phases

Respiratory Tract Infections (RTI) caused by susceptible streptococci

0 Actively Recruiting

Acne Vulgaris

3 Actively Recruiting

Phase 1, Phase 2, Early Phase 1, Phase 4

Mitral Valve Prolapse

1 Actively Recruiting

Not Applicable

Hypertrophic Cardiomyopathy

4 Actively Recruiting

Not Applicable, Phase 1, Phase 2

Surgically constructed systemic-pulmonary shunt

0 Actively Recruiting

Respiratory Tract Infections

0 Actively Recruiting

Bacteria, Anaerobic

0 Actively Recruiting

Heart Defects, Congenital

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Bone and Bones

0 Actively Recruiting

Babesiosis

1 Actively Recruiting

Phase 2

Mixed Vaginal Infections

0 Actively Recruiting

Toxoplasmosis

1 Actively Recruiting

Phase 4

Surgical Intervention

0 Actively Recruiting

Pelvic cellulitis caused by Anaerobic Bacterial Infection

0 Actively Recruiting

Bacterial Endocarditis

0 Actively Recruiting

Malaria

0 Actively Recruiting

Acne Vulgaris

0 Actively Recruiting

Vaginal Infections

0 Actively Recruiting

Acquired Immunodeficiency Syndrome

5 Actively Recruiting

Phase 1, Phase 2, Not Applicable

Clindamycin Palmitate Hydrochloride Reviews: What are patients saying about Clindamycin Palmitate Hydrochloride?

5

Patient Review

9/7/2019

Clindamycin Palmitate Hydrochloride for Skin Infection

I had four bug bites that became infected on my leg. The redness and heat were spreading quickly. After just two doses, I noticed a difference in the healing process. So far, there have been no side effects!

4.7

Patient Review

5/26/2009

Clindamycin Palmitate Hydrochloride for Skin Infection

My daughter had an infected spider bite that tested positive for MRSA. We started using CP Soap 3 times a day and after the first day, saw real results. The infection gradually went away with no adverse effects noted.

3.3

Patient Review

8/3/2011

Clindamycin Palmitate Hydrochloride for Skin Infection

The taste of this medicine is incredibly unpleasant, as other reviewers have noted. However, it has been very effective in reducing the size of my daughter's infection overnight. If you can get your child to take it, it's definitely worth considering.

3.3

Patient Review

4/15/2013

Clindamycin Palmitate Hydrochloride for Infection Within the Abdomen

It was very difficult to get our 14 month old to take this medication because of the taste and smell. We tried chocolate syrup, but it only worked a couple of times. We ended up using dark fudge cake frosting, which helped a little bit. It still wasn't easy, but I'm glad the medication cleared up her infection.

2.3

Patient Review

5/30/2012

Clindamycin Palmitate Hydrochloride for Skin Infection

Unfortunately, I had to stop using this medication after a few days due to some bothersome side effects. These included a rash on my right forearm as well as a dull headache. My doctor is currently prescribing something else for me.

1

Patient Review

4/4/2009

Clindamycin Palmitate Hydrochloride for Sinus Irritation and Congestion

The smell of this medication made me nauseous. I was not surprised that my 4 year old autistic child could not tolerate it either; it's incredibly pungent.

1

Patient Review

1/24/2011

Clindamycin Palmitate Hydrochloride for Skin Infection due to Streptococcus Pyogenes Bacteria

My two year old son couldn't keep this down because of the taste and smell.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about clindamycin palmitate hydrochloride

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is clindamycin palmitate hydrochloride used for?

"This antibiotic is used to treat serious bacterial infections. It works by stopping the growth of bacteria. This antibiotic will not work for viral infections."

Answered by AI

What is Clindamycin Palmitate Hydrochloride for Oral Solution?

"This medication is used to treat infections caused by bacteria. It works by killing bacteria or preventing their growth."

Answered by AI

What infections will clindamycin treat?

"- Clindamycin is a medication used to treat various types of infections. It can be used to treat septicemia, intra-abdominal infections, lower respiratory infections, gynecological infections, bone and joint infections, and skin and skin structure infections."

Answered by AI

What are the side effects of clindamycin palmitate hydrochloride?

"If you have any of the following symptoms, you may have listeriosis:

-A blistering, peeling, red skin rash.

-Unusual bleeding, bruising, or weakness.

-Fever, chills, cough, sore throat, body aches.

-Severe diarrhea that does not go away, stomach cramps."

Answered by AI

Clinical Trials for Clindamycin Palmitate Hydrochloride

Image of New Jersey Community Research Initiative in Newark, United States.

AI-DBT for Suicide Prevention in HIV/AIDS

18+
All Sexes
Newark, NJ

One in four older persons living with HIV/AIDS (PLWHA) report at least one suicide attempt in their lifetime, and the risk for death by suicide is 100 times higher in PLWHA than in the general population. Currently, there are no behavioral interventions that specifically address suicide prevention for older PLWHA, despite their unique biopsychosocial and structural risk factors. Through this work, investigators will adapt Dialectical Behavior Therapy, an evidence-based intervention for suicide prevention, for patients with PLWHA to be delivered by an AI-powered conversational Agent developed by our industry partner, Empower Health. Investigators will then pilot test the feasibility, usability, acceptability and preliminary efficacy to improve self-efficacy to manage negative emotions in n=50 older adults living with HIV/AIDS.

Recruiting
Has No Placebo

New Jersey Community Research Initiative (+1 Sites)

Elissa Kozlov, PhD

Image of McGill university Health Centre (Royal victoria Hospital and Montreal General Hospital in Montreal, Canada.

Systemic Corticosteroids for Pneumocystis Pneumonia

18+
All Sexes
Montreal, Canada

The HOW LONG trial is an international, multicenter, Phase IV randomized clinical trial evaluating the optimal duration of adjunctive systemic corticosteroids in immunocompromised adults with severe Pneumocystis jirovecii pneumonia (PCP) who demonstrate early clinical recovery. Participants who no longer require supplemental oxygen by day 10 of corticosteroid therapy are randomized to discontinue corticosteroids at day 10 (or hospital discharge, if earlier) versus continue corticosteroids for a total of 21 days. The trial assesses whether earlier discontinuation reduces steroid-related complications while maintaining clinical outcomes.

Phase 4
Waitlist Available

McGill university Health Centre (Royal victoria Hospital and Montreal General Hospital

Image of Los Angeles General Medical Center in Los Angeles, United States.

Decision Support Tool for HIV Treatment

18+
All Sexes
Los Angeles, CA

This study is testing software designed to help healthcare providers choose the best HIV treatment combinations for their patients. HIV medicines, known as antiretroviral therapy (ART), can be complex to manage because the right regimen depends on many factors-such as drug resistance, other health conditions, and medication schedules. Many people with HIV are cared for by general clinicians who may not have access to HIV specialists, which can make treatment decisions more challenging. In this study, healthcare providers will use patient cases to compare standard HIV treatment resources with a new clinical decision support tool that gives evidence-based ART recommendations at the point of care. The investigators hypothesize that using the tool will help providers select treatment plans that better match clinical guidelines, make decisions faster, reduce mental effort, and increase overall satisfaction with the prescribing process.

Waitlist Available
Has No Placebo

Los Angeles General Medical Center

Hayoun Lee, PhD

Have you considered Clindamycin Palmitate Hydrochloride clinical trials?

We made a collection of clinical trials featuring Clindamycin Palmitate Hydrochloride, we think they might fit your search criteria.
Go to Trials
Image of Montefiore Medical Center in Bronx, United States.

myPACE+ Algorithm for Hypertrophic Cardiomyopathy

18+
All Sexes
Bronx, NY

This will be a two-arm investigator-initiated randomized controlled study of patients with nHCM and LV ejection fraction ≥50% and NYHA II-III symptoms, normal intrinsic conduction system and pre-existing suitable dual-chamber implantable cardioverter defibrillators (ICD) systems. Patients will be randomly assigned to either personalized accelerated pacing (using the myPACE+ algorithm with mono-fractional exponent) or usual care groups. At baseline and after 3 months of pacing all patients will undergo a CPET, echocardiogram, blood work for NT-proBNP levels and complete the KCCQ-OSS and HCMSQ, questionnaires. The investigator team hypothesizes that personalized accelerated pacing will be safe and improve symptoms and heart-failure related quality of life, physical activity, pVO2, biomarkers (i.e. NT-proBNP), diastolic parameters and cardiac structure.

Recruiting
Has No Placebo

Montefiore Medical Center (+1 Sites)

Sandhya Murthy, MD

Medtronic

Image of Texas Tech University Health Sciences Center in Lubbock, United States.

Amoxicillin Challenge for Penicillin Allergy

18 - 89
All Sexes
Lubbock, TX

The goal of this clinical trial is to learn about dosing when testing to see if a penicillin allergy label can be removed from adults that had been labeled as "penicillin-allergic" previously. The main question it aims to answer is: \- In penicillin-allergic patients that are at low risk of having an allergic reaction, is a one-dose oral challenge with amoxicillin (a penicillin-based antibiotic) as safe and effective as a two-dose oral challenge? Participants will, after being identified as having a low-risk penicillin allergy, be administered oral amoxicillin in a controlled setting and then monitored for an allergic reaction. Researchers will compare participants that took one dose of amoxicillin to participants that took two doses of amoxicillin (a small dose and then a larger dose) to see if either group was more likely to develop an allergic reaction.

Phase 3
Recruiting

Texas Tech University Health Sciences Center

James A Tarbox, MD

Have you considered Clindamycin Palmitate Hydrochloride clinical trials?

We made a collection of clinical trials featuring Clindamycin Palmitate Hydrochloride, we think they might fit your search criteria.
Go to Trials
Image of University of California - San Francisco in San Francisco, United States.

Exercise Program for Hypertrophic Cardiomyopathy

18 - 80
All Sexes
San Francisco, CA

The EXCITE-HCM study is a randomized, controlled, blinded clinical trial designed to evaluate the effect of moderate intensity exercise training versus usual physicial activity on the improvement of HCM-related symptoms and cardiac function. About 70 participants will be recruited and randomized on a 1:1 ratio to either moderate intensity training or usual physicial activity interventions. Patients will be followed during a period of 24 weeks and assesesments as physical examination, questionnaires, 12 lead ecg's, biomarker levels, echocardiogram, Cardiac Magnetic resonance, PET and CPET will be performed to evaluate their response to the intervention.

Recruiting
Has No Placebo

University of California - San Francisco

Theodore P Abraham, M.D

Have you considered Clindamycin Palmitate Hydrochloride clinical trials?

We made a collection of clinical trials featuring Clindamycin Palmitate Hydrochloride, we think they might fit your search criteria.
Go to Trials